Corbus Pharmaceuticals Holdings (CRBP) Non Operating Income (2013 - 2026)
Corbus Pharmaceuticals Holdings' Non Operating Income was $1.08 million in Q3 2025, down 37.6% from $1.72 million a year earlier and down 27.9% from the prior quarter.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Non Operating Income (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Corbus Pharmaceuticals Holdings' Non Operating Income was $8.44 million through Sep 30, 2025, up 12.2% year-over-year; for FY2024, it was $8.51 million.
- Non Operating Income shows a five-year compound annual growth rate of 8.5% (FY2019 to FY2024).
- In earlier years, Non Operating Income was $474,000 in FY2023, -$2.51 million in FY2022, $10.35 million in FY2021 (-10.3%) and $11.54 million in FY2020 (+104.2%).
- The Q3 2025 figure marks the lowest quarterly Non Operating Income since Q2 2024.
- Compared with a year earlier, Non Operating Income was higher in three of the last four quarters, with growth averaging 15.8%.
- Per Business Quant data, CRBP's Non Operating Income in the three quarters before Q3 2025 was $1.49 million (Q2 2025), $2.8 million (Q1 2025) and $3.08 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 80.98 Mn | -453.78 Mn | - | 1.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.07 Mn |
| Jun 30, 2026 | 1.15 Mn |
| Mar 31, 2026 | 1.34 Mn |
| Dec 31, 2025 | 1.41 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 991,000.00 |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 2.08 Mn |
| Sep 30, 2023 | -565,000.00 |
| Jun 30, 2023 | -595,000.00 |
| Mar 31, 2023 | -447,787.00 |
| Dec 31, 2022 | -82,233.00 |
| Sep 30, 2022 | -600,264.00 |
| Jun 30, 2022 | -908,878.00 |
| Mar 31, 2022 | -920,083.00 |
| Dec 31, 2021 | 20.96 Mn |
API Access
Corbus Pharmaceuticals Holdings Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();